Just over a month after the first case of contamination in France, One person was detected this Sunday as a carrier of the monkey poxin corsica. The information was shared this Sunday evening by theregional health department (ARS). An adult with mild symptoms for a few days was diagnosed with monkeypox, the disease’s other name, and treated by health officials. “His condition shows no signs of seriousness”indicates the ARS.
No information was filtered about the geographic area in which the patient was located. “This is an adult person with no travel history to a country where the virus is circulating”adds the ARS, without further details.
ALSO READ. Monkeypox: WHO calls for vigilance and transparency
An in-depth epidemiological investigation was carried out by teams from Public Health France and ARS, in collaboration with the treating doctor. “People who were in close contact with this patient have been identified. They have received information from the health authorities on what needs to be done to limit the spread of the virus and management measures have been implemented.” says specialists.
As a reminder, the first confirmed case of monkeypox was discovered in France on May 19th. On Saturday, the Ile-de-France ARS announced that a child had been diagnosed with monkeypox, which also showed no signs of seriousness.
Last Thursday at 2 p.m., the latest Public Health France report reported 330 confirmed cases on national territory, including 227 in Île-de-France. “So far, as in other European countries, these cases have mainly, but not exclusively, occurred in men who have sex with men, with no direct link to people returning from endemic areas. The majority of cases involve multiple sexual partners.”specifies Public Health France in its latest report.
ALSO READ. Several outbreaks of emerging viruses associated with zoonoses in the 21st centurye century
If monkeypox appeared on French territory on May 19, it is in fact a disease that has been endemic in ten African countries since the 1970s.
Symptoms of monkeypox
Monkeypox is a “cutaneous tropism” disease. The symptoms go away on their own, but in some cases they can be severe.
Among the French cases examined, Public Health France reported that 77% had a genito-anal rash, 73% had a rash on another part of the body, 71% had fever and 69% had lymphadenopathy.
Typically, within the first 5 days, monkeypox infection causes:
- Fever ;
- Headache ;
- lymphadenopathy (swollen lymph nodes);
- back pain ;
- myalgia (muscle pain);
- asthenia (fatigue).
Within 1-3 days of the onset of the fever, the patient develops symptoms of a rash, which often begins on the face and then spreads to other parts of the body, including the palms, soles, and mucous membranes. Skin involvement occurs in a single push. Itching is common. Buttons go through different sequential states.
When the scabs fall off, people are no longer contagious.
In the event of symptoms (fever and rash with blisters), it is recommended to contact Samu Center 15, isolate yourself while waiting for medical advice and avoid contact with other people.
Is it a dangerous disease for humans?
The World Health Organization is particularly concerned about the risks this virus poses to vulnerable people, including children and pregnant women.
Severe cases are also related to the level of exposure to the virus, the patient’s medical condition, and the severity of the complications.
Epidemics have been observed for several years in West and Central Africa, where the disease is endemic. While the mortality rate varied enormously between epidemics, it remained below 10% in all documented cases.
Is there a treatment?
There are no specific treatments or vaccines. In contrast, smallpox vaccination has historically been shown to be 85% effective in preventing monkeypox. However, this vaccine is no longer available to the general public after its production stopped following the global eradication of smallpox in the 1980s, which is why the majority of people born after smallpox was eradicated around 40 years ago are not vaccinated .